Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lum

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
QJM : Monthly Journal of the Association of Physicians|October 12, 2023
Elevated risk of multimorbidity post-COVID-19 infection: protective effect of vaccinationF T T Lai, W Liu, Y Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2019
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine DepletionMilind D Chalishazar, Sarah J Wait, Fang Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Nature Medicine|April 25, 2025
Author Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Nature Medicine|March 29, 2019
Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Nature Medicine|March 6, 2019
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Cancer Research|June 26, 2026
BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial SarcomaJinxiu Li, Mary L Nelson, Li Li, et al.
Nature Cancer|February 28, 2022
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncologyKatrin P Guillen, Maihi Fujita, Andrew J Butterfield, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
QJM : Monthly Journal of the Association of Physicians|October 12, 2023
Elevated risk of multimorbidity post-COVID-19 infection: protective effect of vaccinationF T T Lai, W Liu, Y Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2019
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine DepletionMilind D Chalishazar, Sarah J Wait, Fang Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Nature Medicine|April 25, 2025
Author Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Nature Medicine|March 29, 2019
Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Nature Medicine|March 6, 2019
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Cancer Research|June 26, 2026
BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial SarcomaJinxiu Li, Mary L Nelson, Li Li, et al.
Nature Cancer|February 28, 2022
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncologyKatrin P Guillen, Maihi Fujita, Andrew J Butterfield, et al.
Pageof 12